Details for New Drug Application (NDA): 084188
✉ Email this page to a colleague
NDA 084188 describes MYOTONACHOL, which is a drug marketed by Glenwood and is included in one NDA. Additional details are available on the MYOTONACHOL profile page.
The generic ingredient in MYOTONACHOL is bethanechol chloride. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
The generic ingredient in MYOTONACHOL is bethanechol chloride. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
Summary for 084188
| Tradename: | MYOTONACHOL |
| Applicant: | Glenwood |
| Ingredient: | bethanechol chloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084188
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
